Senior Director, SEC Reporting & SOX

Role: Senior Director, SEC Reporting & SOX at Eikon Therapeutics, responsible for leading and scaling external financial reporting, internal controls, and technical accounting functions in a high-growth biopharma environment. Responsibilities include managing SEC filings (10-K, 10-Q, 8-K), overseeing SOX compliance frameworks, ensuring regulatory adherence, and serving as a technical accounting expert for complex transactions. The role acts as a strategic partner to executive leadership, providing guidance on financial governance, risk management, and long-term compliance strategies. Core responsibilities encompass coordinating with internal teams (Legal, FP&A, IT), managing external audits, developing policies, and mentoring the SEC reporting and SOX teams. Qualifications include 15+ years in finance/accounting, with 12+ years in public accounting or industry, and 6+ years in technical accounting, preferably in biotech or life sciences. Deep expertise in US GAAP, SEC regulations, and SOX required, along with experience building scalable processes in high-growth settings. Leadership skills and effective communication are essential, with familiarity in SAP S4/Hana and ActiveDisclosure preferred. The role reports to senior leadership and involves strategic influence across functions. Work setup is not specified, but the role requires operating autonomously with a focus on long-term impact.